YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Dan Reuvers Chief Financial Officer - Nir Naor ICR Healthcare - Mike Vallie Full Conference Call Transcrip…
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Operational Discipline Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1…
Earnings Call Insights: Neuronetics (STIM) Q2 2026 MANAGEMENT VIEW * "I'm pleased to report the second quarter began to reflect our steady execution against the goals I cited last quarter. Total revenue was $41.6 million, up approximately…
Key Points Interested in Neuronetics, Inc.? Here are five stocks we like better. Q2 results improved significantly: Revenue rose 9.1% year over year to $41.6 million, while the net loss narrowed to $3.4 million and adjusted EBITDA turned p…
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventiona…
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventiona…
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventiona…
(RTTNews) - Neuronetics, Inc. (STIM), which provides treatment options for neurohealth disorders, announced that Nir Naor has been appointed Chief Financial Officer or CFO effective July 23, 2026. Separately, the company also promoted Cory…
(RTTNews) - Today's top biotech gainers include Zhengye Biotechnology, a veterinary vaccine manufacturer, which surged, easing Nasdaq delisting concerns; Advanced Biomed, which gained after withdrawing its planned U.S. securities offering…
Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experienceCory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 202…
Neuronetics, Inc. (NASDAQ:STIM) is one of the 10 High Growth Stocks Insiders Are Buying. On July 6, 2026, Neuronetics, Inc. (NASDAQ:STIM) announced that management will participate at B. Riley Securities' Mind, Muscle & Vision Summit, an i…
Neuronetics, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance Drivers New CEO Dan Reuvers is conducting a comprehensive 'listening tour' to evaluate the integrated NeuroStar and Greenbrook business model following shareholde…
Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and materials, while weakness is more pronounced in health care, consumer-facing segments, and real estate. A total of 1468…
* Neuronetics (STIM [https://seekingalpha.com/symbol/STIM]) the maker of NeuroStar Advanced Therapy, on Monday said that Executive Vice President, Chief Financial Officer, and Treasurer Steven E. Pfanstiel will leave the company to pursue…
MALVERN, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suff…
Neuronetics, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Performance and Operational Evolution Achieved the critical milestone of positive operating cash flow in Q4 2025, validating the strategic thesis of the Greenbrook acquisitio…
Image source: The Motley Fool. Date Tuesday, March 17, 2026 at 8:30 a.m. ET Call participants President and Chief Executive Officer — Keith J. Sullivan Incoming President and Chief Executive Officer — Dan Reavers Chief Financial Officer —…
(RTTNews) - Neuronetics, Inc. (STIM), a neurohealth-focused medical device and service provider, announced fourth-quarter and full-year 2025 results reflecting revenue growth. In addition, the firm provided revenue guidance for the first q…
Neuronetics logo Key Points Board appointed Dan Reuvers as CEO effective March 23, as Neuronetics transitions leadership while continuing its strategy to operate a vertically integrated mental-health company combining NeuroStar technology…
The following companies are expected to report earnings prior to market open on 03/17/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Elbit Systems Ltd. (ESLT)is reporting for the quarter ending December 31…
Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industrial…
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transformi…
Teradata (TDC) shares soared more than 25% amid heavy trading after the company overnight reported a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth on an adjusted pro forma basisFull year…
MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming…
MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroheal…
MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroheal…
MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroheal…
MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohea…
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suff…
Investing.com - Canaccord Genuity lowered its price target on Neuronetics (NASDAQ:STIM) to $7.00 from $8.00 on Wednesday, while maintaining a Buy rating on the stock. The medical device company, with a market capitalization of $300 million…
Earnings Call Insights: Neuronetics (STIM) Q2 2025 MANAGEMENT VIEW * CEO Keith Sullivan highlighted a strong second quarter, stating, “We had a strong second quarter at Neuronetics, both in terms of our ability to drive accelerated top lin…
Neuronetics Inc (NASDAQ:STIM [https://www.chartmill.com/stock/quote/STIM/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. While revenue exceeded estimates, the com…
* Neuronetics press release [https://seekingalpha.com/pr/20188747-neuronetics-reports-second-quarter-2025-financial-and-operating-results] (NASDAQ:STIM [https://seekingalpha.com/symbol/STIM]): Q2 GAAP EPS of -$0.15 misses by $0.07. * Reven…
Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth Generated record Greenbrook clinic revenue of $23.0 million in the quarter Reduced cash used in operations to $3.5 million, beating gu…
MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever a…